Norges Bank’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,642,953
Closed -$72.7M 2217
2022
Q3
$72.7M Sell
2,642,953
-731,212
-22% -$18.1M 0.02% 622
2022
Q2
$77.8M Buy
3,374,165
+823,022
+32% +$19.2M 0.02% 589
2022
Q1
$55.6M Hold
2,551,143
0.01% 818
2021
Q4
$54.5M Buy
2,551,143
+8,395
+0.3% +$176K 0.01% 896
2021
Q3
$53.2M Buy
2,542,748
+72,944
+3% +$1.59M 0.01% 888
2021
Q2
$56.9M Sell
2,469,804
-204,518
-8% -$4.7M 0.01% 896
2021
Q1
$59.1M Buy
2,674,322
+27,956
+1% +$647K 0.01% 881
2020
Q4
$49.4M Buy
2,646,366
+415,773
+19% +$6.83M 0.01% 976
2020
Q3
$32.4M Buy
2,230,593
+1,902,038
+579% +$24.2M 0.01% 1108
2020
Q2
$3.68M Sell
328,555
-1,972,394
-86% -$22.2M ﹤0.01% 1902
2020
Q1
$23M Buy
2,300,949
+643,044
+39% +$8.99M 0.01% 1157
2019
Q4
$27.2M Sell
1,657,905
-571,872
-26% -$7.67M 0.01% 1343
2019
Q3
$26.9M Sell
2,229,777
-20,223
-0.9% -$278K 0.01% 1287
2019
Q2
$32.9M Buy
+2,250,000
New +$33.3M 0.01% 1161

Other funds holding CHNG

Norges Bank's CHNG Position: Q4 2022 in Review

Norges Bank sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 2,642,953 shares — an estimated $72.7M sold.

Norges Bank first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $77.8M in Q2 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Norges Bank reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Norges Bank sold 2,642,953 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $72.7M.
  • Norges Bank first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Norges Bank's Change Healthcare Inc. Common Stock position peaked at $77.8M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Norges Bank's 13F filing for Q4 2022, filed 14 Feb 2023.